About the Journal

Clinical & Experimental Oncology is a hybrid access journal which also permits unlimited Internet Access to complete Journal content. The journal includes all major themes like research papers, review papers, case reports, online letters to the editors & brief comments on previously published articles or any other relevant findings pertaining but not limited to the field of medical oncology, surgery, radiotherapy and pediatric oncology.

Journal of Clinical & Experimental Oncology (JCEOG) (ISSN: 2324-9110) aims to establish channels of communication between academic and research scientific experts by making accessible to the health community, policy makers and to improve medical research worldwide. The journal is dedicated to increasing the depth of medicine and medical sciences across disciplines with the coverage of all areas medical oncology, surgery, radiotherapy, pediatric oncology, cancer diagnosis and therapy.

Scope of the Journal: We accept articles pertaining but not limited to the following topics in Oncology:

Cancer Treatment

For treating the cancer, there are various types of treatment existing based on the impact of the cancer and its effect such as chemotherapy, Radio therapy, immune therapy, Oncologic Surgery, hormone therapy.

Prostate Cancer

Prostate is an exocrine gland of the body of male reproductive system; prostate cancer is mostly a very slow progressing disease. Cancer starts with tiny alterations in the shape and size of the prostate gland cells and leads to Prostate cancer.

Breast Cancer

The cancerous tissue developed in breast is called breast cancer, it may form like lump, and the most common type of breast cancer is ductal carcinoma, which begins in the cells of the ducts.

Skin Cancer

Growth of destructive malicious (carcinogens) on the skin is called Skin Cancer.  Originating from the Epidermis cells (Superficial layer) of the skin, it spreads to the entire parts of the body.

Colorectal Cancer

Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine. Most colorectal cancers are adenocarcinomas..

Gastrointestinal Cancer: It is a collective term of cancers that occur in the digestive system which includes oesophagus, stomach, biliary tract, liver, pancreas, small intestine and the large intestine.

Pediatric Oncology

Pediatric Oncology includes the research work in the treatment of cancers that occur in infants and children.

Head and Neck Cancer

Head and Neck Cancer include the cancers related to mouth, sinuses, nose and throat.

Carcinogens

Carcinogens are the cancer causing agents. Carcinogens are may be of natural or chemical induced or may be artificial. Carcinogenesis or oncogenesis or tumor genesis is literally the 'creation' of cancer. It is a process by which normal cells are transformed into cancer cells.

Neoplasm

Neoplasm is termed as an abnormal growth of cells or tissues (tumor) particularly when they become the cancer causing agents.

Psycho-oncology

Psycho-oncology is a specialty in cancer care concerned with understanding and treating the social, psychological, emotional, spiritual, quality-of-life and functional aspects of people affected by cancer.

Apoptosis

Apoptosis happens ordinarily amid improvement and maturing and as a homeostatic component to keep up cell populaces in tissues. Apoptosis additionally happens as a safeguard instrument, for example, in insusceptible responses or when cells are harmed via malady or harmful agents.

Cancer Epidemiology

Cancer Epidemiology is also known as cancer detection or cancer prevention. It is the complete study of cancer which includes the factors causing it, and the ways to prevent and treat various types of cancers.

Oncogenes

An Oncogene is a gene that can possibly bring about cancer. In tumor cells, they are frequently transformed or communicated at high levels. These cells causes rapid cell deaths of normal cells and even malfunction the working cells.

Tumor Immunology

 Tumor Immunology is a branch of immunology that studies communications between immune and cancerous cells (tumors or malignancies). It is a developing field of examination that plans to find imaginative growth immunotherapies to treat and retard movement of the infection.

To know more, email your query at editorialoffice@scitechnol.comQueries will be answered within 48 hours.

Procedure for review:

Articles submitted by authors are evaluated by a group of peer review experts using Online Submission System for quality in review process. Editorial Tracking is an Online Submission System, review and tracking systems. Review processing is performed by the editorial board members of Journal of Clinical & Experimental Oncology or outside experts. At least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Impact Factor:

*2017 Journal Impact Factor is the ratio of the number of citations achieved in the year 2017 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2015 and 2016. Impact factor measures the quality of the Journal.

If ‘X’ is the total number of articles published in 2015 and 2016, and ‘Y’ is the number of times these articles were cited in indexed journals during 2017 then, impact factor = Y/X

Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Clinical & Experimental Oncology is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.